Menu

• Ask a Health Expert about FACTOR V LEIDEN MUTATION
• Post Your Side Effect related to FACTOR V LEIDEN MUTATION
• FACTOR V LEIDEN MUTATION and FDA Warnings
• FACTOR V LEIDEN MUTATION in Patients Wiki
• Report FACTOR V LEIDEN MUTATION in Drug Side Effect Survey

FACTOR V LEIDEN MUTATION side effect

What is FACTOR V LEIDEN MUTATION ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Nuvaring Side Effects Report #5291457-5
Consumer or non-health professional from UNITED STATES reported NUVARING problem on Mar 21, 2007. Female patient, 29 years of age, weighting 175.0 lb, was diagnosed with contraception and was treated with NUVARING. After drug was administered, patient experienced the following problems/side effects: factor v leiden mutation, pulmonary embolism, . NUVARING dosage: unknown. During the same period patient was treated with LEVAQUIN. Patient was hospitalized. Patient recovered.

Cerezyme Side Effects Report #5794832-5
CEREZYME problem was reported by a Physician from GERMANY on June 12, 2008. Male patient, 51 years of age, was diagnosed with gaucher's disease and was treated with CEREZYME. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, factor v leiden mutation, . CEREZYME dosage: unknown. Patient recovered.

Micrette Side Effects Report #5341753-8
Physician from TURKEY reported MICRETTE problem on May 15, 2007. Female patient, 42 years of age, was diagnosed with menstruation irregular and was treated with MICRETTE. After drug was administered, patient experienced the following problems/side effects: activated protein c resistance, factor v leiden mutation, fibrin d dimer increased, hereditary angioedema, purpura fulminans, red blood cell sedimentation rate increased, skin discolouration, skin necrosis, . MICRETTE dosage: unknown. Patient was hospitalized. Patient recovered.

Tysabri Side Effects Report #5629019-X
TYSABRI problem was reported by a Physician from UNITED STATES on Feb 06, 2008. Female patient, 47 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: decubitus ulcer, deep vein thrombosis, factor v leiden mutation, protein s deficiency, . TYSABRI dosage: 300 MG;QM;IV. During the same period patient was treated with NEXIUM, CYMBALTA, KLONOPIN, BACLOFEN, VITAMIN D, CALCIUM, CRANBERRY SUPPLEMENT, MILK OF MAGNESIA. Patient was hospitalized. Patient recovered.


Natalizumab Side Effects Report #5573690-8
Consumer or non-health professional from UNITED STATES reported NATALIZUMAB problem on Dec 07, 2007. Female patient, 47 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: decubitus ulcer, deep vein thrombosis, factor v leiden mutation, hypercoagulation, protein s deficiency, . NATALIZUMAB dosage: 300 MG; QM; IV. During the same period patient was treated with NEXIUM, CYMBALTA, KLONOPIN, BACLOFEN, VITAMIN D, CALCIUM, CRANBERRY SUPPLEMENT, MILK OF MAGNESIA. Patient was hospitalized. Patient recovered.

Azathioprine Side Effects Report #5575898-4
AZATHIOPRINE problem was reported by a Consumer or non-health professional from NETHERLANDS on Dec 18, 2007. Female patient, 24 years of age, was diagnosed with immunosuppression and was treated with AZATHIOPRINE. After drug was administered, patient experienced the following problems/side effects: ascites, blood alkaline phosphatase increased, factor v leiden mutation, gamma-glutamyltransferase increased, oesophageal varices haemorrhage, platelet count decreased, portal hypertensive gastropathy, protein s decreased, . AZATHIOPRINE dosage: 75 MG;DAILY. During the same period patient was treated with CYCLOSPORINE, ANTITHYMOCYTE IMMUNOGLOBULIN, PREDNISONE, TACROLIMUS. Patient recovered.

Microgestin Side Effects Report #5352336-8
Pharmacist from UNITED STATES reported MICROGESTIN problem on June 07, 2007. Female patient, 17 years of age, was treated with MICROGESTIN. After drug was administered, patient experienced the following problems/side effects: antithrombin iii decreased, deep vein thrombosis, factor v leiden mutation, . MICROGESTIN dosage: unknown. During the same period patient was treated with VICODIN. Patient was hospitalized. Patient recovered.